Top-News
Shareholder Alert: The Ademi Firm investigates whether Hologic Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Oct. 21, 2025 /PRNewswire/ -- The Ademi Firm is investigating Hologic (Nasdaq: HOLX) for possible breaches of fiduciary duty and other violations of law in its transaction with Blackstone and TPG.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, Hologic shareholders will receive $76 per share in cash plus a contingent value right of up to $3 per share. The contingent payments would be made in two installments of up to $1.50 each, contingent on achieving certain global revenue goals for Hologic's Breast Health business in fiscal years 2026 and 2027. Hologic insiders will continue to receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Hologic by imposing a significant penalty if Hologic accepts a competing bid. We are investigating the conduct of the Hologic board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & Fruchter LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ademi-firm-investigates-whether-hologic-inc-is-obtaining-a-fair-price-for-its-public-shareholders-302590338.html
SOURCE Ademi LLP
Für dich aus unserer Redaktion zusammengestellt
Dein Kommentar zum Artikel im Forum
Jetzt anmelden und diskutieren
Registrieren
Login
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.